Fundraising Fox
🦊/Companies
Sign in

Invitrolize

Founded 2022 · 7 employees on LinkedIn · 1 known investors

Find your way into Invitrolize

A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.

BiotechDeep TechHealthtechMedical Devices

Investors · 1

Expon CapitalLuxembourg · $550K – $1.6M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Invitrolize secures seed funding from Expon Capital - Startup Luxembourgstartupluxembourg.com · May 2025INVITROLIZE SECURES SEED INVESTMENT FROM EXPON CAPITAL TO EXPAND ALISENS® DEPLOYMENT ACROSS EUROPE AND THE US - Expon Capitalexponcapital.com · May 2025How I did my first fundraising: Turning science into strategy - Startup Luxembourgstartupluxembourg.com

Frequently asked questions

What does Invitrolize do?
A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.
Who are Invitrolize's investors?
Invitrolize's investors include Expon Capital.